Faculty of Medicine ,South Valley University
试验速览
- 阶段
- 2 期
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- progression of covid 19 clinical picture
研究概览
简要总结
Ivermectin showed a strong viricidal effect upon covid19 virus in vitro as proved by many authors according to many studies , covid virus stay in postnasal space for 4 days before starting general manifestation, so ivermectin mucoadhesive nanosuspension sprayed inside the nose and post nasal space may help in early management of covid19 and may play a great rule in prophylaxis as well
详细描述
150 patient with early covid is devided into two groups first group will receive regular protocol of drugs second group will receive ivermectin nasal spray in addition to regular protocl of drugs
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •early covid19 pateints
排除标准
- •children and pregnant women
研究组 & 干预措施
intranasal Ivermectin group
Ivermectin group Patients who will receive intranasal ivermectin
干预措施: intranasal ivermectin spray (Drug)
Control group
patients who will receive regular protocol drugs
干预措施: intranasal ivermectin spray (Drug)
结局指标
主要结局
progression of covid 19 clinical picture
时间窗: [ Time Frame: within 14 days after enrollement ]
progress of Symptoms ( Fever ,Cough, Sore Throat, Myalgia,Diarrhea, Shortness of Breath)with radiological assesment and blood tests
次要结局
未报告次要终点
研究者
Zaky Aref
ass.professor
South Valley University